MedPath

StemCells, Inc.

🇺🇸United States
Ownership
Private, Subsidiary
Established
1992-01-01
Employees
-
Market Cap
-
Website
http://stemcellsinc.com

Clinical Trials

10

Active:0
Completed:5

Trial Phases

2 Phases

Phase 1:5
Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 1
5 (71.4%)
Phase 2
2 (28.6%)

Study of HUCNS-SC Subretinal Transplantation in Subjects With GA of AMD

Phase 2
Terminated
Conditions
Age-Related Macular Degeneration
First Posted Date
2015-06-10
Last Posted Date
2016-06-02
Lead Sponsor
StemCells, Inc.
Target Recruit Count
3
Registration Number
NCT02467634
Locations
🇺🇸

Retina Associates Southwest, PC, Tucson, Arizona, United States

🇺🇸

Retina Vitreous Associates Medical Group, Beverly Hills, California, United States

🇺🇸

Retinal Diagnostic Center, Campbell, California, United States

and more 8 locations

Study of Human Central Nervous System (CNS) Stem Cell Transplantation in Cervical Spinal Cord Injury

Phase 2
Terminated
Conditions
Spine Injury
Cervical Spine Injury
Cervical Spinal Cord Injury
Interventions
Drug: HuCNS-SC cells
First Posted Date
2014-06-16
Last Posted Date
2016-06-02
Lead Sponsor
StemCells, Inc.
Target Recruit Count
31
Registration Number
NCT02163876
Locations
🇺🇸

Rancho Los Amigos National Rehabilitation Center/USC, Downey, California, United States

🇺🇸

University of Miami Miller School of Medicine, Miami, Florida, United States

🇺🇸

Northwestern University, Chicago, Illinois, United States

and more 11 locations

Long-Term Follow-up Safety Study of Human Central Nervous System Stem Cells in Subjects With Geographic Atrophy of Age-Related Macular Degeneration

Terminated
Conditions
Geographic Atrophy
Age-Related Macular Degeneration
First Posted Date
2014-05-14
Last Posted Date
2016-06-02
Lead Sponsor
StemCells, Inc.
Target Recruit Count
8
Registration Number
NCT02137915
Locations
🇺🇸

Retina Foundation of the Southwest, Dallas, Texas, United States

Long-Term Follow-Up of Transplanted Human Central Nervous System Stem Cells (HuCNS-SC) in Spinal Cord Trauma Subjects

Terminated
Conditions
Spinal Cord Injury
First Posted Date
2012-11-14
Last Posted Date
2016-06-03
Lead Sponsor
StemCells, Inc.
Target Recruit Count
12
Registration Number
NCT01725880
Locations
🇨🇭

Uniklinik Balgrist, Zurich, Switzerland

Study of Human Central Nervous System Stem Cells (HuCNS-SC) in Age-Related Macular Degeneration (AMD)

Phase 1
Completed
Conditions
Macular Degeneration
Age Related Macular Degeneration
AMD
Interventions
Drug: HuCNS-SC cells
First Posted Date
2012-07-03
Last Posted Date
2015-09-14
Lead Sponsor
StemCells, Inc.
Target Recruit Count
15
Registration Number
NCT01632527
Locations
🇺🇸

Retina-Vitreaous Associates Medical Group, Los Angeles, California, United States

🇺🇸

Byers Eye Institute at Stanford, Stanford Hospital and Clinics, Palo Alto, California, United States

🇺🇸

New York Eye and Ear Infirmary, New York, New York, United States

and more 2 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.